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ABSTRACT  
The present study deals with the phytochemical screening and evaluation of antiasthmatic activity of methanolic extract of Trigonella 
foenumgraecum on experimental models of bronchial asthma and anaphylaxis. The antiasthmatic activity was studied on histamine-induced 
bronchospasm in guinea pig (Dunkey-Hartley) for respiratory parameters such as maximum airflow, minimum airflow, tidal volume, 
respiratory rate, minute volume, specific airway resistance determination on double chambered whole body plethysmography on un-
anesthetized guinea pigs, for mast cell degranulation by compound 48/80 (in vitro) was done using rat (Albino Wistar) peritoneal fluid. 
Trigonella foenum graecum treated result indicated significant protection against histamine-induced bronchospasm in guinea pigs at highest 
dose i.e. 400mg/kg. The bronchodilatory effect of Trigonella foenum graecum was found comparable to the protection offered by the standard 
drug Salbutamol on respiratory parameters in double chambered whole body plethysmography, Treatment with Trigonella foenum graecum at 
a dose of 400mg/kg showed a significant decrease in degranulation rate of actively and passively sensitized mast cells of sensitized rats when 
challenged with antigen. Trigonella foenum graecum. Possess significant anti-asthmatic activity due to its potential anti inflammatory, 
antioxidant and the antihistaminic activity, which reflects as anti-degranulating effect on mast cells and on respiratory parameters.  
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INTRODUCTION: 
Asthma is a serious condition in which the bronchial tubes 
become swollen, hyperproduction of mucus results in a 
reduction in size, which is characterized by airway 
inflammation and difficulty in breathing.1  All of these 
pathological changes in asthma are mediated by common 
inflammatory mediators like histamine, tryptase, and other 
neutral proteases, leukotrienes C4 & D4 and prostaglandins 
which are released by infiltrating of inflammatory cells, 
including eosinophils, mast cells, and lymphocytes 
responsible for the early reaction (immediate 
bronchoconstriction).2  Asthma is a complex disease in which 
the repeated exposure of  many types of allergens  leads to 
aggravation of asthma attack some of them are dust particles, 
pollens, exercise, pets in houses, insects like- dust mites in 
mattresses, pillows, carpets, curtains  smoke from tobacco, 
wood, agarbattis, changes in weather foods drugs like 
aspirin, β-blockers  and viral respiratory infections.3 Asthma 
affects over 20 million individuals in the US and over 60 
million individuals worldwide. It affects over 5-10% of the 
population in industrialized countries.4,5 In India 57.5 
estimated total deaths (2,000); 5.1 estimated deaths per 
100000 population; 277 DALYs (disability-adjusted life-year) 
per 100,000; 6.5 age-standardized deaths per 100,000; 
constitutes 0.2% of all deaths and 0.5% of National burden of 
diseases.[4,5] Common symptoms which observed in asthma 
are a shortness of breath, wheezing, coughing and a tight 
feeling in the chest.6 Even though research in respiratory 
medicine is in advanced stages, respiratory diseases are still 
one of the perpetrators of global health. Despite the 
availability of a wide range of drugs such as steroids, β2-
agonists, anticholinergic and phosphodiesterase (PDE) 
inhibitors, the relief offered by them is mainly symptomatic, 
short-lived and have numerous adverse effects. For example, 
longer use of corticosteroids produces a deficiency in bone 
mineral density, cardiovascular effects, osteoporosis and 
osteonecrosis, the risk of cataract, panniculitis, migraine or a 
migraine-like headache, pharyngitis and sore throat and 
renal deterioration. Most recently, it has been reported to 
cause serious pneumonia also. The long-actingβ2-
adrenoreceptor agonists produce myocardial ischemia and 
Jain et al                                                                                                                  Journal of Drug Delivery & Therapeutics. 2020; 10(1):101-106 
ISSN: 2250-1177                                                                                  [102]                                                                                 CODEN (USA): JDDTAO 
osteoporosis. Anticholinergics cause papillary dilation, 
blurred vision, and acute glaucoma. PDE inhibitors like 
theophylline cause gastrointestinal symptoms to 
palpitations, arrhythmias, hypocalcemia, nausea, 
diarrhea,and headache, Hence the search for a new drug is 
still the need of the day.7,8 Trigonella foenum gracecum. 
(Fabaceae) is commonly known as “Methi” in Hindi, and is 
used as a vegetable and cultivated throughout India, Sri 
Lanka, and many other tropical countries.9 The plant 
contains steroids, saponins, ß-sitosterol, flavonoids, 
terpenoids, glycosides, alkaloids, phenolic compounds, 
betalains, tannins, amino acids, lysine and tryptophan, and 4-
hydroxyisoleucine,Steroidal saponins (fenugreek in 
diosgenin) flavonoids as flavone glycosides (apigenin, 
luteolin, quercetin), Coumarins.10, 11 Tribal people use 
decoction (15-20 ml) of the whole plant thrice daily in 
allergic bronchitis and asthma as folk medicine11 However, 
no scientific studies are carried out to investigate the anti-
asthmatic and anti-anaphylactic effect of seeds of Trigonella 
foenum gracecum, Hence the present study is carried out to 
evaluate the anti-asthmatic activity of seeds of Trigonella 
foenum gracecum.7,8  Therefore, need to develop the novel 
treatment for asthma with fewer side effects, and for this 
purpose, Trigonella foenum-graecum which is natural 
product can be used as new therapy. However, its exact 
effects on allergic asthma have been still rarely studied, and 
need to be verified. In the present study, we aimed to 
investigate the effects of Trigonella foenum-graecum on 
airway inflammation of allergic asthma in Histamine-induced 
bronchospasm in guinea pigs, Restrained double chamber 
body plethysmography measurements, Compound 48/80-
induced Mast cell degranulation. 
MATERIALS AND METHODS: 
 Plant material: 
The plant was collected from a local area of Chopda in 
Maharashtra state in the month of March and May. The plant 
was authenticated by Dr. S. R. Kshirsagar, Reader, P.G. 
Department of Botany, S.S.V.P.S Science College, Dhule- 425 
405 (MS).The Seeds were dried under shade and then 
powdered. The powder was then extracted with 70% 
methanol by using soxhlet apparatus. 
Phytochemical investigations: 
The obtained methanolic extract was tested for various 
chemical constituents with the help of qualitative chemical 
tests.[12] 
Animals: 
Adult Guinea pig (Dunkey-Hartley) of body weight 500-700 g 
and Mice (Swiss Albino) of body weight25-30 gm mice of 
either sex obtained from Wokhart institute, Aurangabad was 
used for the experiment. 
Rat (Albino Wistar) of body weight 200-250 g were obtained 
from in-house animal house facility of the institute, Standard 
conditions of temperature (22 ± 2oC), relative humidity (60 
± 5%) and light (12 hrs light/dark cycles) were maintained, 
standard feed and water were given ad libitum. The study 
was approved by the Institutional Animal Ethics Committee 
(IAEC) of R.C.P.I.P.E.R, Shirpur, India and according to 
CPCSEA guideline. Registration no: 651/02/c/CPCSEA. 
Histamine-induced bronchospasm in guinea pigs 
Histamine-induced bronchospasm in guinea pigs was carried 
out by the reported method 13-15 Adult Guinea pigs of weight 
around 500-700 gm of either sex were divided into 5 groups 
(From I to V) Control group receives 1ml of saline solution 
while standard group receives Chlorpheniramine maleate 2 
mg/kg and the remaining 3 groups receives 200mg/kg, 
300mg/kg, and 400mg/kg respectively. Twenty-five guinea 
pigs then were exposed to 0.5 % histamine diphosphate H-
7375 (Sigma chemicals 23297-93-0) with constant pressure 
40mm/Hg in an aerosol chamber to induce experimental 
bronchial asthma. This PCT was considered as T1 value. 
These animals were subjected to histamine challenge two 
and a half hr. after receiving the drug. The PCT was noted. 
This PCT was considered as T2 value. Animals which 
withstood exposure to histamine aerosol for 15 min were 
considered to be completely protected. The protection 
offered by the treatment was calculated by the following 
formula. 
 
Where; T1 is a time in second for PCT before treatment T2 is 
the time in second for PCT after treatment. 
Restrained double chamber body plethysmography 
measurements for histamine-induced 
bronchoconstriction in unanesthetized guinea pigs 
Awaken guinea pigs were divided into different groups as 
shown in table no. 1 and individually placed in a body 
plethysmograph box (HSE type 855, Hugo Sachs Elektronik, 
Germany) and were exposed to histamine in a concentration 
of 0.5% solution for 10 seconds.16 The histamine aerosol was 
generated by a jet nebulizer (PARI Jet-Nebulizer requires an 
operating pressure of approx. 1.5 bar.,100% of the particles 
are below 10 μm) are delivered to the head chamber of the 
plethysmograph and respiratory frequency and amplitude 
were recorded. Respiratory function in animals was 
evaluated by measurement of ventilatory parameters 
[respiratory rate (RR), tidal volume (VT) and minute 
ventilation, specific airway resistance measurement (RV)]. 
 
Table 1: Experimental design for histamine induced bronchospasm. 
Groups (n) Name of group Drug received Dose (p.o.) 
Group I (5) Control Normal saline 1 mL 
Group II (5) Test drug TFME      200 mg/kg 
Group III (5) Test drug TFME      300mg/kg 
Group IV (5) Test drug TFME      400mg/kg 
Group V (5) Standard drug (Std.) Chlorpheniramine maleate 2 mg/kg 
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Compound 48/80-induced Mast cell degranulation:  
Wistar rats of weight around 150-180 g of either sex were 
divided into six groups containing six animals in each. 
Normal control group receives only methylcellulose 
suspension 0.1ml while all remaining groups receive 
compound 48/80 (10 µg/ml) standard treated group 
receives Ketotifen (10 mg/ml) Test I, Test II and Test III 
receives TFME 200mg/kg, 300mg/kg and 400mg/kg 
respectively17, 18.The suspensions were further incubated for 
10 min at 37°C. The peritoneal mast cells were stained with 
toluidine blue and examined microscopically for intact and 
disrupted mast cells. A minimum of 100 cells was counted 
for the number of intact and degranulated mast cells. 
Statistical analysis: 
The results of various studies were expressed as mean ± 
SEM and analyzed statistically using One-way ANOVA 
followed by Dunnett’s multiple comparative post-test to find 
out the level of significance. P < 0.05 was considered 
statistically significant. The analysis was performed using 
the GraphPad Prism software package (version 5.0). 
 
 
 
 
RESULTS 
Phytochemical Screening: 
TFME showed the presence of amino acids, proteins, 
Carbohydrates, Alkaloids and saponins like steroids and 
triterpenoids while showed the absence of Tannins, 
Flavonoids. 
% yield: 
The yield of TFME was found to be 8.77% w/w. 
Acute toxicity study: 
LD50 was reported20 Acute Oral Toxicity > 5gm/kg Acute 
Dermal Toxicity > 2gm/kg 
Bronchial hyperactivity: 
Histamine-induced bronchospasm in guinea pigs  
Preconvulsion time is directly proportional to 
bronchodilator and antihistaminic activity. The dyspnea was 
evoked within 30.40±1.54seconds in the control group on 
exposure of histamine aerosol, In case of standard 
(Chlorpheniramine), it was 209.40±12.20seconds. While 
after the treatment with T. foenum graecum at a dose of 200, 
300, 400 mg/kg, p.o., of extract PCT was prolonged up to 
65.00±10.9, 132±8.17, 184±12.3 seconds under same 
conditions. The result indicates that T. foenum graecum 
at200, 300 and 400 mg/kg showed significant protection 
when compared with chlorpheniramine maleate. 
 
 
Figure 1: A. Effect of methanolic extract of T. foenum graecum on histamine aerosol-induced bronchospasm B. Effect of 
methanolic extract of T. foenum graecum Protection against histamine-induced bronchospasm Value represents, Mean ± S.E.M. 
(n=5) ANOVA: Dunnett’s Multiple Comparative test *p< 0.05, **p<0.01, ***p<0.001 as Compared with Control. 
 
 
Restrained double chamber whole body plethysmography 
measurements for histamine-induced 
bronchoconstriction in unanesthetized guinea pigs:- 
Histamine inhalation in double chamber whole body 
plethysmography shows decreased in a respiratory 
amplitude (diminished respiratory volume due to 
bronchoconstriction) and the reflectory increase of 
respiratory frequency, this seems to be attenuated by T. 
foenum graecum at the concentration of 200, 300and 400 
mg/kg showed elevations in Respiratory function by 
measurement of ventilatory parameters [respiratory rate 
(RR), tidal volume (VT) and minute ventilation, specific 
airway resistance measurement (RV)].  
 
Jain et al                                                                                                                  Journal of Drug Delivery & Therapeutics. 2020; 10(1):101-106 
ISSN: 2250-1177                                                                                  [104]                                                                                 CODEN (USA): JDDTAO 
 
Figure 2: Effect of methanolic extract of T.foenum graecum on (A) Maximum airflow (B) Minimum Airflow. 
 
Figure 3: Effect of methanolic extract of T.foenum graecum on (A) Tidal Volume (B) Respiratory Rate. 
 
Figure 4: Effect of methanolic extract of T.foenum graecum on (A) Minute volume (B) Specific Airway Resistance (Rxv_1). 
Values are expressed as mean ± SEM (n=6), One way ANOVA: Dunnett’s Multiple Comparative Test. #p<0.01 when compared 
with normal control group, *p<0.05, **p< 0.01, ***p<0.001 when compared with Histamine. 
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Evaluation of Mast Cell Stabilization Activity:- 
Compound 48:80-induced Mast cell degranulation: 
Compound 48/80 (10 µg/ml) produced about 77.2% 
degranulation of mast cells as compared to normal control 
group. Groups treated with standard drug Ketotifen (0.1 
mg/ml) showed 75±1.91 (p<0.01) intact mast cells whereas 
T. foenum graecum showed significant (p<0.01) and dose-
dependent protection against the mast cell degranulation 
compared to Compound 48/80 group. T. foenum graecum at 
the concentration of 200, 300and 400 mg/kg 
showed38.2±1.7,51.7±2.2 and 63.3±1.50 % intact mast cells 
respectively. Standard reference Ketotifen (0.1 mg/ml) 
showed comparative mast cell stabilization with T. foenum 
graecum.
 
 
Figure 5: Images of granulated & de-granulated mast cells. 
 
Figure 6: Effect of methanolic extract of T.foenum graecum on compound 48/80 induced Mast cell degranulation: (A) Intact 
Cells (B) Degranulated cells Values are expressed as mean ± SEM (n=6), One Way ANOVA: Dunnett’s Multiple Comparative Test. 
#p<0.01 when compared with normal control group, *p< 0.05, **p< 0.01, ***p<0.001 when compared with Sensitized Control. 
 
DISCUSSION 
The bronchoconstriction appeared in the early stage of 
asthma is caused due to the release of inflammatory 
mediators like histamine, leukotrienes, prostaglandins, 
tryptase, and acetylcholine.15 T. foenum graecum seems to be 
a promising plant for treatment of bronchial asthma because 
the plant is a rich source of different phytoconstituents with 
a variety of potential biological activities and for 
bronchodilation activity. T. foenum graecum proved Anti-
inflammatory activity. The plant contains steroidal Saponins 
which inhibits the release of several mediators of the 
phlogistic agents such as prostaglandins, histamine, 
serotonin, and bradykinin by inhibiting the biosynthetic 
pathways of inflammatory mediators. Evidence strongly 
suggests that steroidal Saponins present in the extracts 
obtained from T. foenum graecum may interfere with 
lipoxygenase and/or cyclo-oxygenase pathway, Histamine is 
an important mediator of immediate allergic and 
inflammatory reaction and it induce bronchoconstriction, it 
acts through H1, receptors through the IP3-DAG pathway, 
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releases Ca2+ from intracellular stores and protein kinase-C 
activation.21 In the present study histamine, 0.5% solution 
acts as spasmogens in the form of aerosols for 10 Sec. to 
cause significant bronchoconstriction in and it results into 
an overall reduction in airway due to bronchoconstriction in 
guinea pigs. In the reference standard group, we used the 
standard drug Chlorpheniramine maleate and Salbutamol 
against histamine-induced bronchospasm. The crude 
methanolic extract at a dose of 200mg/kg, 300mg/kg, and 
400mg/kg orally 30 min. before the histamine challenge has 
shown significant bronchoprotection against spasmogens as 
compared to control the significant effect produced may be 
due to the inhibition of IP3-DAG pathway or inhibition of 
releases of Ca2+ from intracellular stores or inhibition of 
protein kinase-C activation. The bronchodilatory effect of 
T.foenum graecum was found comparable to the protection 
offered by the standard drug Chlorpheniramine maleate and 
salbutamol. 
Asthma is an inﬂammatory disease of the lungs 
characterized by increased inﬁltration of leukocytes into the 
airways and reduced respiratory function. The inﬂammation 
leads to bronchoconstriction, increased airway 
hyperreactivity, and mucus production22 after antigen 
challenge, inflammatory leukocytes produce various 
chemical mediators which are thought to be involved in both 
the immediate and the late asthmatic responses. During the 
LAR infiltration of eosinophils, neutrophils, lymphocytes, 
monocytes into the airways have been identified in BALF 
from the asthmatics23 Mast cells, which are constituents of 
virtually all organs and tissue, are important mediators of 
inﬂammatory responses such as allergy and anaphylaxis. 
Mast cell degranulation can be elicited non-immunologically 
by the most potent synthetic secretagogue compound 48/80, 
which is a condensation product of N-methoxyphenylamine 
with formaldehyde and a high dose of which induces almost 
a 90% release of histamine from mast cells. To study the 
mechanism of anaphylaxis Compound 48/80 has been used 
[17, 18] it increases the permeability of the lipid bilayer 
membrane of the cell by causing a perturbation in the 
membrane and initiates the activation of a signal 
transduction pathway, which leads to degranulation and 
histamine release17 The intracellular calcium (Ca2+) 
pathways are critical to the degranulation of mast cells. T. 
foenum graecum attenuated rate of mast cell degranulation 
dose-dependently as observed microscopically by toluidine 
blue staining. 
CONCLUSION 
Thus, it can be concluded from the results obtained in the 
present pharmacological investigation that T. foenum 
graecum possess: Anti-asthmatic activity, Anti-histaminic 
activity Anti-degranulating activity Anti-allergic activity this 
may be attributed to Mast cell stabilization, inhibiting the 
release of histamine from the mast cells. Further study is 
needed to identify, isolate, purify and evaluate active 
constituent present in the T. foenum graecum for its anti-
asthmatic activity. 
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